{"id":"https://openalex.org/W1970548642","doi":"https://doi.org/10.1128/aac.49.11.4658-4666.2005","title":"Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam","display_name":"Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam","publication_year":2005,"publication_date":"2005-10-26","ids":{"openalex":"https://openalex.org/W1970548642","doi":"https://doi.org/10.1128/aac.49.11.4658-4666.2005","mag":"1970548642","pmid":"https://pubmed.ncbi.nlm.nih.gov/16251309","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1280174"},"language":"en","primary_location":{"id":"doi:10.1128/aac.49.11.4658-4666.2005","doi":"https://doi.org/10.1128/aac.49.11.4658-4666.2005","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.49.11.4658-4666.2005","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1280174","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112349996","display_name":"Johannes Breedt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johannes Breedt","raw_affiliation_strings":["Eugene Marais Hospital, Les Marais, Pretoria, Republic of South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eugene Marais Hospital, Les Marais, Pretoria, Republic of South Africa","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007312217","display_name":"J\u00fcri Teras","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093692","display_name":"North Estonia Medical Centre","ror":"https://ror.org/00kfp3012","country_code":"EE","type":"healthcare","lineage":["https://openalex.org/I4210093692"]}],"countries":["EE"],"is_corresponding":false,"raw_author_name":"Ju\u0308ri Teras","raw_affiliation_strings":["North Estonian Regional Hospital, Clinic of Surgery, Tallinn, Estonia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North Estonian Regional Hospital, Clinic of Surgery, Tallinn, Estonia","institution_ids":["https://openalex.org/I4210093692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077152126","display_name":"J\u0101nis Gardovskis","orcid":"https://orcid.org/0000-0001-9656-6209","observed_orcids":["https://orcid.org/0000-0001-9656-6209","https://orcid.org/0000-0002-7817-4268"]},"institutions":[{"id":"https://openalex.org/I4210099352","display_name":"Pauls Stradi\u0146\u0161 Clinical University Hospital","ror":"https://ror.org/00h1aq868","country_code":"LV","type":"healthcare","lineage":["https://openalex.org/I4210099352"]}],"countries":["LV"],"is_corresponding":false,"raw_author_name":"Janis Gardovskis","raw_affiliation_strings":["P. Stradina Clinical University Hospital, Medical Academy of Latvia, Riga, Latvia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"P. Stradina Clinical University Hospital, Medical Academy of Latvia, Riga, Latvia","institution_ids":["https://openalex.org/I4210099352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110252351","display_name":"Frans Jacobus Maritz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26092322","display_name":"Stellenbosch University","ror":"https://ror.org/05bk57929","country_code":"ZA","type":"education","lineage":["https://openalex.org/I26092322"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Frans Jacobus Maritz","raw_affiliation_strings":["Tijger Trial Centre, Karl Bremer and University of Stellenbosch, Bellville, Republic of South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tijger Trial Centre, Karl Bremer and University of Stellenbosch, Bellville, Republic of South Africa","institution_ids":["https://openalex.org/I26092322"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068003114","display_name":"T. Vaasna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802241215","display_name":"Tartu University Hospital","ror":"https://ror.org/01dm91j21","country_code":"EE","type":"healthcare","lineage":["https://openalex.org/I2802241215"]}],"countries":["EE"],"is_corresponding":false,"raw_author_name":"Tiit Vaasna","raw_affiliation_strings":["Tartu University Clinics, Tartu, Estonia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tartu University Clinics, Tartu, Estonia","institution_ids":["https://openalex.org/I2802241215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070383090","display_name":"Douglas Patrick Ross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133745","display_name":"St. Mary\u2019s Hospital","ror":"https://ror.org/041j39g66","country_code":"ZA","type":"healthcare","lineage":["https://openalex.org/I4210133745"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Douglas Patrick Ross","raw_affiliation_strings":["St. Mary's Hospital, Durban, Republic of South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Mary's Hospital, Durban, Republic of South Africa","institution_ids":["https://openalex.org/I4210133745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016756371","display_name":"Martine Gioud-Paquet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martine Gioud-Paquet","raw_affiliation_strings":["Clinical Research and Development, Wyeth Research, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research and Development, Wyeth Research, Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052948853","display_name":"Nathalie Dartois","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathalie Dartois","raw_affiliation_strings":["Clinical Research and Development, Wyeth Research, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research and Development, Wyeth Research, Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013759582","display_name":"Evelyn J. Ellis\u2010Grosse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evelyn J. Ellis-Grosse","raw_affiliation_strings":["Clinical Research and Development, Wyeth Research, Collegeville, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research and Development, Wyeth Research, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055169513","display_name":"Evan Loh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evan Loh","raw_affiliation_strings":["Clinical Research and Development, Wyeth Research, Collegeville, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research and Development, Wyeth Research, Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4403928396"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":13.8146,"has_fulltext":false,"cited_by_count":190,"citation_normalized_percentile":{"value":0.99317696,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"49","issue":"11","first_page":"4658","last_page":"4666"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.5957000255584717,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.5957000255584717,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.2809999883174896,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11080","display_name":"Surgical site infection prevention","score":0.023000000044703484,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tigecycline","display_name":"tigecycline","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.7919999957084656},{"id":"https://openalex.org/keywords/aztreonam","display_name":"aztreonam","score":0.9990000128746033},{"id":"https://openalex.org/keywords/skin-and-skin-structure-infections","display_name":"skin and skin structure infections","score":0.9049999713897705},{"id":"https://openalex.org/keywords/combination-antibiotic-therapy","display_name":"combination antibiotic therapy","score":0.6489999890327454},{"id":"https://openalex.org/keywords/clinical-response","display_name":"clinical response","score":0.5389999747276306},{"id":"https://openalex.org/keywords/microbiologic-eradication","display_name":"microbiologic eradication","score":0.9900000095367432},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6579999923706055},{"id":"https://openalex.org/keywords/nausea-and-vomiting","display_name":"nausea and vomiting","score":0.4869999885559082},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.5400000214576721},{"id":"https://openalex.org/keywords/alanine-aminotransferase","display_name":"alanine aminotransferase","score":0.8090000152587891},{"id":"https://openalex.org/keywords/aspartate-aminotransferase","display_name":"aspartate aminotransferase","score":0.9399999976158142}],"concepts":[{"id":"https://openalex.org/C2777027569","wikidata":"https://www.wikidata.org/wiki/Q420595","display_name":"Tigecycline","level":3,"score":0.8948154449462891},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8466440439224243},{"id":"https://openalex.org/C2780416669","wikidata":"https://www.wikidata.org/wiki/Q418546","display_name":"Aztreonam","level":5,"score":0.7734754681587219},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5849921107292175},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5705037713050842},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5521900057792664},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5380911231040955},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.5048666596412659},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.42805594205856323},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4199317991733551},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.26317310333251953},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.08961442112922668},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.07038450241088867},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.06559157371520996},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000078304","descriptor_name":"Tigecycline","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000410","descriptor_name":"Alanine Transaminase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001219","descriptor_name":"Aspartate Aminotransferases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001398","descriptor_name":"Aztreonam","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001398","descriptor_name":"Aztreonam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008911","descriptor_name":"Minocycline","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008911","descriptor_name":"Minocycline","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008911","descriptor_name":"Minocycline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017192","descriptor_name":"Skin Diseases, Bacterial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.49.11.4658-4666.2005","doi":"https://doi.org/10.1128/aac.49.11.4658-4666.2005","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.49.11.4658-4666.2005","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1280174","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1280174","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:16251309","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16251309","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1280174","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1280174","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1581962345","https://openalex.org/W1925363657","https://openalex.org/W1963881598","https://openalex.org/W1966540801","https://openalex.org/W1973393074","https://openalex.org/W1993543372","https://openalex.org/W2008228367","https://openalex.org/W2011682266","https://openalex.org/W2019235971","https://openalex.org/W2020018978","https://openalex.org/W2027422681","https://openalex.org/W2031303083","https://openalex.org/W2034482054","https://openalex.org/W2067540185","https://openalex.org/W2069416660","https://openalex.org/W2087901245","https://openalex.org/W2094747692","https://openalex.org/W2098180498","https://openalex.org/W2104923518","https://openalex.org/W2112111953","https://openalex.org/W2113588525","https://openalex.org/W2115562145","https://openalex.org/W2137591261","https://openalex.org/W2139316387","https://openalex.org/W2143941770","https://openalex.org/W2153590024","https://openalex.org/W2155606734","https://openalex.org/W2156737450","https://openalex.org/W2170206890","https://openalex.org/W2259390332","https://openalex.org/W4285719527","https://openalex.org/W4302577372"],"related_works":["https://openalex.org/W2040587302","https://openalex.org/W1999311088","https://openalex.org/W7095497414","https://openalex.org/W4235470435","https://openalex.org/W2146844783","https://openalex.org/W4390914398","https://openalex.org/W2059072492","https://openalex.org/W2135543196","https://openalex.org/W2087470294","https://openalex.org/W2034482054"],"abstract_inverted_index":{"In":[0],"a":[1],"randomized,":[2],"double-blind,":[3],"controlled":[4],"trial,":[5],"546":[6],"patients":[7,112,203,210,228],"with":[8,238],"complicated":[9,282],"skin":[10,12,283,285],"and":[11,23,42,70,105,129,150,154,176,206,213,241,248,254,259,267,276,284],"structure":[13,286],"infections":[14],"received":[15],"tigecycline":[16,149,205,246],"100":[17],"mg/day":[18],"(a":[19],"100-mg":[20],"initial":[21],"dose":[22],"then":[24],"50":[25],"mg":[26],"intravenously":[27,39,48],"twice":[28,40,49],"daily)":[29,41,50],"or":[30,196],"the":[31,61,65,76,84,91,116,148,151,160,177,202,209,235,245,264,279],"combination":[32,124,139,152,265],"of":[33,201,208,227,252,281],"vancomycin":[34,153,212,266],"2":[35],"g/day":[36,45],"(1":[37],"g":[38,47],"aztreonam":[43,155,214,268],"4":[44],"(2":[46],"for":[51,278],"up":[52],"to":[53,80,273],"14":[54],"days.":[55],"The":[56,87,144,225],"primary":[57],"end":[58],"point":[59],"was":[60,94,98,271],"clinical":[62,66,145],"response":[63,89],"in":[64,115,147,159,199,234,244,256,263],"modified":[67],"intent-to-treat":[68],"(c-mITT)":[69],"clinically":[71,132],"evaluable":[72,133],"(CE)":[73],"populations":[74],"at":[75,90],"test-of-cure":[77,92],"visit":[78,93],"12":[79],"92":[81],"days":[82],"after":[83],"last":[85],"dose.":[86],"microbiologic":[88],"also":[95],"assessed.":[96],"Safety":[97],"assessed":[99],"by":[100],"physical":[101],"examination,":[102],"laboratory":[103],"results,":[104],"adverse":[106,230],"event":[107],"reporting.":[108],"Five":[109],"hundred":[110],"twenty":[111],"were":[113,131,157,232],"included":[114],"c-mITT":[117,161],"population":[118,162,179],"(tigecycline":[119,134],"group,":[120,125,135,140],"n":[121,126,136,141],"=":[122,127,137,142,174,191,223],"261;":[123],"259),":[128],"436":[130],"223;":[138],"213).":[143],"responses":[146],"groups":[156],"similar":[158,233],"(84.3%":[163],"versus":[164,181],"86.9%;":[165],"difference,":[166,183],"-2.6%":[167],"[95%":[168,185,217],"confidence":[169,186,218],"interval,":[170,187,219],"-9.0,":[171],"3.8];":[172],"P":[173,190,222],"0.4755)":[175],"CE":[178],"(89.7%":[180],"94.4%;":[182],"-4.7%":[184],"-10.2,":[188],"0.8];":[189],"0.1015).":[192],"Microbiologic":[193],"eradication":[194],"(documented":[195],"presumed)":[197],"occurred":[198],"84.8%":[200],"receiving":[204,211],"93.2%":[207],"(difference,":[215],"-8.5":[216],"-16.0,":[220],"-1.0];":[221],"0.0243).":[224],"numbers":[226],"reporting":[229],"events":[231],"two":[236],"groups,":[237],"increased":[239,250],"nausea":[240],"vomiting":[242],"rates":[243],"group":[247],"an":[249],"incidence":[251],"rash":[253],"increases":[255],"alanine":[257],"aminotransferase":[258,261],"aspartate":[260],"levels":[262],"group.":[269],"Tigecycline":[270],"shown":[272],"be":[274],"safe":[275],"effective":[277],"treatment":[280],"infections.":[287]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}